ADVERTISEMENT

ICICI Direct: Sanofi India’s Margins Upbeat Despite Covid-19 Disturbances

ICICI Direct expects future launches by Sanofi India from its global staple and brand extensions to drive the drugmaker’s growth.

Blister packs containing Priadel tablets, produced by Sanofi, sit on a pharmacy counter in this arranged photograph in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)
Blister packs containing Priadel tablets, produced by Sanofi, sit on a pharmacy counter in this arranged photograph in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More